PHM vs TERN · P/E 7.7, rev $17.95B vs $6.12B cap
PulteGroup Inc (PHM) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PHM currently screens at market cap $21.92B and trailing P/E 7.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PHM and TERN stock pages for the full models.
Not investment advice.